Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 33,373 | 49,651 | 49,724 | 50,681 | 40,772 |
| Operating Income | -33,373 | -49,651 | -49,724 | -50,681 | -40,772 |
| Interest Expense | 743 | 672 | 691 | 543 | 194 |
| Other Income | 24 | 6 | 29 | 37 | 40 |
| Pre-tax Income | -34,092 | -50,317 | -50,386 | -51,187 | -40,926 |
| Net Income Continuous | -34,092 | -50,317 | -50,386 | -51,187 | -40,926 |
| Net Income | $-34,092 | $-50,317 | $-50,386 | $-51,187 | $-40,926 |
| EPS Basic Total Ops | -0.85 | -1.32 | -1.33 | -1.35 | -1.09 |
| EPS Basic Continuous Ops | -0.85 | -1.32 | -1.33 | -1.35 | -1.09 |
| EPS Diluted Total Ops | -0.85 | -1.32 | -1.33 | -1.35 | -1.09 |
| EPS Diluted Continuous Ops | -0.85 | -1.32 | -1.33 | -1.35 | -1.09 |
| EBITDA(a) | $-33,100 | $-49,391 | $-49,515 | $-50,515 | $-40,687 |